XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net income $ 34,656 $ 31,701
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for loan losses 12,679 15,500
Depreciation, amortization and accretion, net 10,131 8,795
Change in cash surrender value of bank owned life insurance (2,211) (1,293)
Stock-based compensation expense 786 604
Operating lease payments (2,161) (2,092)
Gain on investment securities, net (88) (913)
(Gain) loss on sales and write downs of other real estate owned, net 6,870 (427)
Gain on sale of other assets (154) (26)
Gain on sale of loans held for sale, net (3,426) (3,484)
(Increase) decrease in accrued interest receivable 195 (4,651)
Decrease in accrued interest payable (519) (237)
Origination of loans held for sale (113,630) (144,814)
Proceeds from sale of loans held for sale 117,083 145,716
Increase in other investment (442) (101)
Increase in other assets (18,326) (5,735)
Increase (decrease) in other liabilities 5,236 (5,479)
Net cash provided by operating activities 46,679 33,064
Cash flows from investing activities:    
Proceeds from maturities of certificates of deposit investments 245 2,910
Purchases of certificates of deposit investments (245) (980)
Proceeds from sales of securities available-for-sale 611 3,417
Proceeds from maturities of securities available-for-sale 182,803 292,091
Proceeds from maturities of securities held-to-maturity 0 15,000
Purchases of securities available-for-sale (552,294) (291,282)
Net (increase) decrease in loans 16,683 (539,867)
Purchases of premises and equipment (2,367) (2,688)
Proceeds from sales of other real property owned 8,602 1,777
Investment in banked owned life insurance (30,000) 0
Net cash provided by acquisition 27,061 0
Net cash used in investing activities (348,901) (519,622)
Cash flows from financing activities:    
Net increase in deposits 305,368 702,470
Decrease in federal funds purchased 0 (5,000)
Decrease in repurchase agreements (57,046) (37,764)
Proceeds from FHLB advances 5,000 19,000
Repayment of FHLB advances (14,000) (39,000)
Proceeds from short-term debt 0 5,000
Repayment of short-term debt 0 (5,000)
Proceeds from issuance of common stock 1,724 473
Direct expenses related to capital transactions (144) 0
Dividends paid on common stock (10,755) (6,316)
Net cash provided by financing activities 230,147 633,863
Increase (decrease) in cash and cash equivalents (72,075) 147,305
Cash and cash equivalents at beginning of period 417,281 85,080
Cash and cash equivalents at end of period 345,206 232,385
Cash paid during the period for:    
Interest 11,483 13,022
Income taxes 14,306 18,624
Supplemental disclosures of noncash investing and financing activities    
Loans transferred to other real estate 237 214
Dividends reinvested in common stock 333 336
Net tax benefit related to option and deferred compensation plans 0 22
LINCO Bancshares, Inc.    
Supplemental disclosures of noncash investing and financing activities    
Fair value of assets acquired 1,170,699 0
Cash paid 103,500 0
Common stock issued 44,191 0
Total consideration paid 147,691 0
Fair value of liabilities assumed $ 1,023,008 $ 0